Brand Name | Status | Last Update |
---|---|---|
aminosyn ii | New Drug Application | 2022-05-04 |
aminosyn-pf | New Drug Application | 2022-07-21 |
clinimix | New Drug Application | 2021-04-13 |
clinimix e | New Drug Application | 2021-04-13 |
clinisol | ANDA | 2018-06-01 |
kabiven | New Drug Application | 2023-08-02 |
novoseven | Biologic Licensing Application | 2010-08-06 |
perikabiven | New Drug Application | 2023-08-07 |
plenamine | ANDA | 2023-04-21 |
premasol - sulfite-free (amino acid) | ANDA | 2022-08-04 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | — | 1 | — | 1 | — | 2 |
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | — | — | 1 | — | 2 |
Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | — | — | — | 1 | — | 1 |
Asthma | D001249 | EFO_0000270 | J45 | — | — | — | 1 | — | 1 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | 1 | — | 1 |
Pancreas transplantation | D016035 | — | — | — | — | — | 1 | — | 1 |
Thoracic aortic aneurysm | D017545 | EFO_0004282 | — | — | — | — | 1 | — | 1 |
Meningococcal infections | D008589 | EFO_0004249 | A39 | — | — | — | 1 | — | 1 |
Inborn genetic diseases | D030342 | EFO_0000508 | — | — | — | — | 1 | — | 1 |
Aging | D000375 | GO_0007568 | R41.81 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Covid-19 | D000086382 | — | U07.1 | 1 | 4 | 4 | — | — | 7 |
Severe acute respiratory syndrome-related coronavirus | D045473 | NCBITaxon_227859 | — | — | 1 | 1 | — | — | 2 |
Menkes kinky hair syndrome | D007706 | — | — | 1 | 1 | 1 | — | — | 2 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | — | 1 | 1 | — | — | 1 |
Leukocyte disorders | D007960 | — | D72.9 | — | 1 | 1 | — | — | 1 |
Macular edema | D008269 | — | — | — | — | 1 | — | — | 1 |
Communicable diseases | D003141 | — | — | — | — | 1 | — | — | 1 |
Virus diseases | D014777 | — | B34 | — | — | 1 | — | — | 1 |
Rna virus infections | D012327 | — | — | — | — | 1 | — | — | 1 |
Rabies | D011818 | — | A82 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 2 | — | — | 1 | 3 |
Falciparum malaria | D016778 | EFO_0007444 | B50 | 1 | 1 | — | — | 2 | 3 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 1 | — | — | — | 2 |
Chronic renal insufficiency | D051436 | — | N18 | 1 | 1 | — | — | — | 2 |
Coronary artery disease | D003324 | — | I25.1 | — | 2 | — | — | — | 2 |
Melanoma | D008545 | — | — | 1 | 2 | — | — | — | 2 |
Mesothelioma | D008654 | — | C45 | — | 1 | — | — | — | 1 |
Gonorrhea | D006069 | DOID_7551 | A54 | — | 1 | — | — | — | 1 |
Retinitis pigmentosa | D012174 | HP_0000580 | H35.52 | 1 | 1 | — | — | — | 1 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 3 | — | — | — | 1 | 4 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 2 | — | — | — | — | 2 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 1 | — | — | — | 1 | 2 |
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | — | — | — | 1 |
Mycoses | D009181 | — | B35-B49 | 1 | — | — | — | — | 1 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 1 | — | — | — | — | 1 |
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | — | 1 |
Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | — | — | — | — | 1 |
Chronic pain | D059350 | HP_0012532 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Malaria | D008288 | EFO_0001068 | B54 | — | — | — | — | 4 | 4 |
Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | — | — | — | 1 | 1 |
Intestinal diseases | D007410 | HP_0002242 | K63.9 | — | — | — | — | 1 | 1 |
Hepatic encephalopathy | D006501 | — | K72.91 | — | — | — | — | 1 | 1 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | — | 1 | 1 |
Cachexia | D002100 | HP_0004326 | R64 | — | — | — | — | 1 | 1 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 1 | 1 |
Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 1 | 1 |
Metabolism | D008660 | GO_0008152 | — | — | — | — | — | 1 | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
Drug common name | Histidine |
INN | histidine |
Description | L-histidine is the L-enantiomer of the amino acid histidine. It has a role as a nutraceutical, a micronutrient, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a human metabolite, an algal metabolite and a mouse metabolite. It is a proteinogenic amino acid, a histidine and a L-alpha-amino acid. It is a conjugate base of a L-histidinium(1+). It is a conjugate acid of a L-histidinate(1-). It is an enantiomer of a D-histidine. It is a tautomer of a L-histidine zwitterion. |
Classification | Small molecule |
Drug class | H2-receptor antagonists (cimetidine type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N[C@@H](Cc1c[nH]cn1)C(=O)O |
PDB | — |
CAS-ID | 71-00-1 |
RxCUI | — |
ChEMBL ID | CHEMBL17962 |
ChEBI ID | 15971 |
PubChem CID | 6274 |
DrugBank | DB00117 |
UNII ID | 4QD397987E (ChemIDplus, GSRS) |